Nuvation Bio NUVB Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $164.09M+359% | $35.72M-16.2% | $42.65M-57.8% | $101.1M-23.7% | ||
| $365.13M-21.8% | $466.97M-17.9% | $568.56M+1.5% | $559.92M-11.5% | ||
| $27.5M+112% | $12.95M— | —— | —— | ||
| $11.41M— | $0— | —— | —— | ||
| $571.52M+8.6% | $526.26M-14.6% | $616.43M-7.6% | $667.32M-13.6% | ||
| $564K-3.8% | $586K-18.3% | $717K-19.8% | $894K+13.7% | ||
| $11.21M+143% | $4.62M— | $0— | —— | ||
| $594.82M+10.0% | $540.63M-13.0% | $621.48M-7.5% | $672.14M-13.4% | ||
| $57.8M+119% | $26.38M+161% | $10.1M-63.3% | $27.54M+40.6% | ||
| $7.52M-32.4% | $11.12M— | $0— | —— | ||
| $5.72M-8.9% | $6.28M— | $0— | —— | ||
| $5.72M-8.9% | $6.28M— | $0— | —— | ||
| $82.23M+41.2% | $58.24M+317% | $13.97M+6.2% | $13.16M-22.2% | ||
| $47.21M— | $0— | —— | —— | ||
| $289.11M+276% | $76.84M+370% | $16.36M-4.1% | $17.07M-43.4% | ||
| $1.42B+310% | $346.5M-63.4% | $947.75M+2.2% | $927.6M+1.9% | ||
| -$1.12B-22.5% | -$910.74M-166% | -$342.8M-28.4% | -$267M-64.0% | ||
| $305.72M-34.1% | $463.79M-23.4% | $605.12M-7.6% | $655.08M-12.2% | ||
| $594.82M+10.0% | $540.63M-13.0% | $621.48M-7.5% | $672.14M-13.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Nuvation Bio cover its short-term obligations?
- Its current ratio is 7.44 — current assets exceed current liabilities.
- Where does Nuvation Bio's balance sheet data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.